SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-079914
Filing Date
2012-02-27
Accepted
2012-02-27 08:06:01
Documents
4
Period of Report
2012-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d307149d8k.htm 8-K 15610
2 PRESS RELEASE d307149dex991.htm EX-99.1 652072
3 GRAPHIC g307149g30t49.jpg GRAPHIC 3734
4 GRAPHIC g307149g82u53.jpg GRAPHIC 8496
  Complete submission text file 0001193125-12-079914.txt   686180
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 12640175
SIC: 2834 Pharmaceutical Preparations